Year Wise Statistics
Total Downloads
636,277
Fulltext
55,443
PDF
580,834
636,277
Fulltext
55,443
580,834
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
EditorialEczema and skin allergy-focus on researchFull text |  PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_29_2024 |
712 | 59,951 | 60,663 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_52_2023 |
1,669 | 43,272 | 44,941 |
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_39_2023 |
575 | 40,732 | 41,307 |
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_31_2023 |
1,050 | 39,977 | 41,027 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_45_2023 |
1,066 | 39,017 | 40,083 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDF DOI: 10.25259/IJSA_15_2024 |
1,054 | 37,938 | 38,992 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDF DOI: 10.25259/IJSA_37_2023 |
919 | 36,252 | 37,171 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_14_2024 |
476 | 34,543 | 35,019 |
CommentaryStatus of research and publication in IndiaFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_29_2023 |
830 | 30,640 | 31,470 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDF DOI: 10.25259/IJSA_26_2023 |
833 | 23,546 | 24,379 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_6_2024 |
436 | 20,162 | 20,598 |
ImageGiant fixed drug eruptionFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_47_2023 |
1,602 | 13,418 | 15,020 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_44_2023 |
1,894 | 12,900 | 14,794 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF DOI: 10.25259/IJSA_3_2024 |
396 | 12,158 | 12,554 |
Case ReportA novel pitch against the itchFull text | PDF DOI: 10.25259/IJSA_13_2024 |
421 | 11,062 | 11,483 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_1_2024 |
764 | 10,534 | 11,298 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDF DOI: 10.25259/IJSA_42_2023 |
554 | 10,458 | 11,012 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_9_2024 |
514 | 9,232 | 9,746 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_48_2023 |
1,417 | 7,978 | 9,395 |
SymposiumCutaneous photobiologyFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_11_2024 |
1,149 | 8,122 | 9,271 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_28_2023 |
1,385 | 7,807 | 9,192 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text | PDF DOI: 10.25259/IJSA_4_2024 |
497 | 8,045 | 8,542 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text | PDF DOI: 10.25259/IJSA_31_2024 |
372 | 8,074 | 8,446 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_51_2023 |
1,520 | 6,812 | 8,332 |
SymposiumPolymorphous light eruptionsFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_8_2024 |
544 | 7,462 | 8,006 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_5_2024 |
1,231 | 6,512 | 7,743 |
SymposiumChronic actinic dermatitisFull text | PDF Year: 2024, Volume: 3, Issue: 1, January-June DOI: 10.25259/IJSA_10_2024 |
437 | 5,650 | 6,087 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDF DOI: 10.25259/IJSA_19_2024 |
236 | 5,717 | 5,953 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_21_2022 |
593 | 3,450 | 4,043 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_25_2023 |
515 | 3,520 | 4,035 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_30_2023 |
563 | 3,427 | 3,990 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text | PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_3_2021 |
2,924 | 269 | 3,193 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text | PDF DOI: 10.25259/IJSA_30_2024 |
318 | 2,709 | 3,027 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_5_2021 |
2,229 | 207 | 2,436 |
ImageLocalized allergic contact dermatitis on skin flap: Unveiling immune privilege in non-immune privileged sitesFull text | PDF DOI: 10.25259/IJSA_23_2024 |
309 | 1,580 | 1,889 |
Review ArticleJAK inhibitors in dermatologyFull text | PDF Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_7_2021 |
1,270 | 218 | 1,488 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text | PDF Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_22_2022 |
676 | 726 | 1,402 |
Letter to EditorExosome therapy in atopic dermatitis – A way to look forwardFull text | PDF Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_26_2022 |
496 | 797 | 1,293 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_14_2023 |
1,097 | 169 | 1,266 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_20_2023 |
1,123 | 138 | 1,261 |
ObituaryObituary: Dr. A. K. Bajaj (1945–2021)Full text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_1_2022 |
1,048 | 130 | 1,178 |
Review ArticleLigelizumab: A novel molecule in the management of chronic spontaneous urticariaFull text | PDF Year: 2023, Volume: 2, Issue: 1, January-June DOI: 10.25259/IJSA_8_2023 |
451 | 710 | 1,161 |
Conference ReportConference report: 8th Annual National Skin Allergy Meeting – IndiaFull text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_2_2022 |
893 | 174 | 1,067 |
Original ArticleComparative assessment of quality of life in chronic spontaneous urticaria receiving second generation anti histamines: A real world studyFull text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_2_2021 |
882 | 116 | 998 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text | PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_11_2021 |
783 | 182 | 965 |
Case ReportSuccessful use of tranexamic acid in the management of child having hereditary angioedema – A case reportFull text | PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_7_2022 |
399 | 534 | 933 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDF Year: 2022, Volume: 1, Issue: 1, January-June DOI: 10.25259/IJSA_12_2021 |
752 | 153 | 905 |
Review ArticleRole of patient-reported outcome measures in the management of chronic urticaria and angioedemaFull text | PDF Year: 2023, Volume: 2, Issue: 2, Jul-Dec DOI: 10.25259/IJSA_6_2022 |
805 | 85 | 890 |
Original ArticleHospital-based cross-sectional study to assess Vitamin D levels in patients of chronic spontaneous urticaria and its relation to severity of disease activityFull text | PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_11_2022 |
660 | 202 | 862 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text | PDF Year: 2022, Volume: 1, Issue: 2, July-December DOI: 10.25259/IJSA_4_2022 |
695 | 158 | 853 |
